RETRACTED: Ahmed et al. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. <i>Nanomaterials</i> 2020, <i>10</i>, 1270

Ngā tūemi rite

• Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation
  mā: Usama A. Fahmy, me ētahi atu.
  I whakaputaina: (2020-05-01)
• RETRACTED: Ahmed et al. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. <i>Nanomaterials</i> 2020, <i>10</i>, 1270
  mā: Osama A. A. Ahmed, me ētahi atu.
  I whakaputaina: (2024-01-01)
• Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment
  mā: Waleed S. Alharbi, me ētahi atu.
  I whakaputaina: (2022-11-01)
• Preparation, characterization, dissolution, and permeation of flibanserin − 2-HP-β-cyclodextrin inclusion complexes
  mā: Adel F. Alghaith, me ētahi atu.
  I whakaputaina: (2021-09-01)
• Development and Greenness Evaluation of Spectrofluorometric Methods for Flibanserin Determination in Dosage Form and Human Urine Samples
  mā: Rasha Ahmed, me ētahi atu.
  I whakaputaina: (2020-10-01)